Bank of New York Mellon’s Corbus Pharmaceuticals CRBP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-23,206
| Closed | -$123K | – | 4140 |
|
2025
Q1 | $123K | Sell |
23,206
-1
| -0% | -$5 | ﹤0.01% | 3953 |
|
2024
Q4 | $274K | Sell |
23,207
-1,069
| -4% | -$12.6K | ﹤0.01% | 3804 |
|
2024
Q3 | $501K | Sell |
24,276
-5,960
| -20% | -$123K | ﹤0.01% | 3509 |
|
2024
Q2 | $1.37M | Buy |
+30,236
| New | +$1.37M | ﹤0.01% | 3006 |
|
2023
Q1 | – | Sell |
-1,069
| Closed | -$3.54K | – | 4391 |
|
2022
Q4 | $3.54K | Sell |
1,069
-74
| -6% | -$245 | ﹤0.01% | 4455 |
|
2022
Q3 | $5K | Hold |
1,143
| – | – | ﹤0.01% | 4532 |
|
2022
Q2 | $9K | Hold |
1,143
| – | – | ﹤0.01% | 4553 |
|
2022
Q1 | $18K | Hold |
1,143
| – | – | ﹤0.01% | 4619 |
|
2021
Q4 | $21K | Hold |
1,143
| – | – | ﹤0.01% | 4580 |
|
2021
Q3 | $35K | Sell |
1,143
-5,431
| -83% | -$166K | ﹤0.01% | 4469 |
|
2021
Q2 | $361K | Sell |
6,574
-2,330
| -26% | -$128K | ﹤0.01% | 3908 |
|
2021
Q1 | $527K | Buy |
8,904
+1,357
| +18% | +$80.3K | ﹤0.01% | 3656 |
|
2020
Q4 | $282K | Sell |
7,547
-1,546
| -17% | -$57.8K | ﹤0.01% | 3852 |
|
2020
Q3 | $492K | Buy |
9,093
+72
| +0.8% | +$3.9K | ﹤0.01% | 3497 |
|
2020
Q2 | $2.27M | Buy |
9,021
+1,757
| +24% | +$442K | ﹤0.01% | 2606 |
|
2020
Q1 | $1.14M | Buy |
7,264
+624
| +9% | +$98.2K | ﹤0.01% | 2879 |
|
2019
Q4 | $1.09M | Buy |
6,640
+134
| +2% | +$22K | ﹤0.01% | 3200 |
|
2019
Q3 | $951K | Sell |
6,506
-498
| -7% | -$72.8K | ﹤0.01% | 3203 |
|
2019
Q2 | $1.46M | Buy |
7,004
+137
| +2% | +$28.5K | ﹤0.01% | 2990 |
|
2019
Q1 | $1.43M | Buy |
6,867
+388
| +6% | +$80.9K | ﹤0.01% | 2957 |
|
2018
Q4 | $1.14M | Buy |
6,479
+543
| +9% | +$95.1K | ﹤0.01% | 3031 |
|
2018
Q3 | $1.34M | Sell |
5,936
-321
| -5% | -$72.7K | ﹤0.01% | 3079 |
|
2018
Q2 | $948K | Sell |
6,257
-68
| -1% | -$10.3K | ﹤0.01% | 3272 |
|
2018
Q1 | $1.16M | Buy |
6,325
+6
| +0.1% | +$1.1K | ﹤0.01% | 3131 |
|
2017
Q4 | $1.35M | Buy |
6,319
+1,314
| +26% | +$280K | ﹤0.01% | 3066 |
|
2017
Q3 | $1.07M | Buy |
5,005
+445
| +10% | +$95.4K | ﹤0.01% | 3178 |
|
2017
Q2 | $862K | Buy |
4,560
+3,857
| +549% | +$729K | ﹤0.01% | 3334 |
|
2017
Q1 | $174K | Buy |
703
+50
| +8% | +$12.4K | ﹤0.01% | 3908 |
|
2016
Q4 | $166K | Sell |
653
-110
| -14% | -$28K | ﹤0.01% | 3939 |
|
2016
Q3 | $155K | Buy |
+763
| New | +$155K | ﹤0.01% | 3947 |
|